Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Common variable immunodeficiency and the gastrointestinal tract.

Ishaan Kalha1, Joseph H Sellin

  • 1Division of Gastroenterology, University of Texas Medical Branch, 301 University Boulevard, Route 0764, Galveston, TX 77555, USA.

Current Gastroenterology Reports
|September 3, 2004
PubMed
Summary

Common variable immunodeficiency (CVID) affects multiple body systems, often impacting the gastrointestinal tract. T-cell defects, not just antibody deficiency, cause these GI issues, necessitating combination therapies beyond immunoglobulin replacement.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "A retrospective cohort study to examine the association between the persistence of abdominal pain after cholecystectomy and ejection fraction on HIDA scan in patients with biliary dyskinesia" [iLIVER 2 (2023) 208-213].

iLIVER·2026
Same author

Unraveling the Complexity: A Case of Systemic Lupus Erythematosus, Warm Autoimmune Hemolytic Anemia, and Autoimmune Cholangitis.

Cureus·2025
Same author

A retrospective cohort study to examine the association between the persistence of abdominal pain after cholecystectomy and ejection fraction on HIDA scan in patients with biliary dyskinesia.

iLIVER·2025
Same author

Relevance of Procalcitonin Levels as a Marker of Severity and Predictor of Mortality, Initiation and Duration of Antibiotics in Patients Admitted with Acute Pancreatitis: A Retrospective Cohort Study.

Clinical and experimental gastroenterology·2024
Same author

Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.

Gastroenterology·2016
Same author

Chronic Diarrhea: Diagnosis and Management.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2016

Area of Science:

  • Immunology
  • Gastroenterology
  • Primary Immunodeficiency Disorders

Background:

  • Common variable immunodeficiency (CVID) is a significant primary immunodeficiency, characterized by combined humoral and cell-mediated immune defects.
  • The gastrointestinal tract, as the body's largest immune organ, is frequently affected in CVID patients.
  • Gastrointestinal manifestations in CVID are diverse, mimicking other diseases but with distinct microscopic features.

Purpose of the Study:

  • To highlight the prevalence and nature of gastrointestinal disorders in patients with Common variable immunodeficiency.
  • To explore the underlying immunological mechanisms contributing to gastrointestinal pathology in CVID.
  • To discuss the limitations of standard therapy and the potential need for alternative treatment strategies.

Main Methods:

Related Experiment Videos

  • Review of existing literature on gastrointestinal manifestations in Common variable immunodeficiency.
  • Analysis of the immunological underpinnings, particularly T-cell mediated defects, in CVID-associated GI conditions.
  • Evaluation of the efficacy of current and potential therapeutic approaches.

Main Results:

  • A high prevalence of inflammatory, malignant, and infectious gastrointestinal disorders is consistently reported in CVID patients.
  • Gastrointestinal symptoms in CVID can mimic conditions like celiac sprue, pernicious anemia, and inflammatory bowel disease.
  • T-cell mediated immune defects are strongly implicated as the primary drivers of gastrointestinal pathology in CVID.

Conclusions:

  • Gastrointestinal manifestations are a critical and complex aspect of Common variable immunodeficiency.
  • The T-cell component of CVID is crucial in understanding and managing its gastrointestinal complications.
  • Intravenous immunoglobulin therapy alone may be insufficient, suggesting a need for immunomodulatory agents in treating CVID-related GI disorders.